Skip to main content
. 2024 Sep 19;7(9):e2434835. doi: 10.1001/jamanetworkopen.2024.34835

Table 1. Inclusion Criteria Following the Population, Intervention, Comparison, Outcome, and Study Design Framework.

Element Inclusion criteria
Population Adults ages ≥18 y with chronic pain or painful muscle spasms (experiencing pain on most days for >3 mo)
Intervention Daily use of an oral nonbenzodiazepine antispasmotic drug(s) for 4 weeks or longer
Comparison Placebo, other pain medication, nonpharmacologic pain treatment, nonexposed cohort, baseline (historical) data
Outcome Any outcome(s) that pertains to pain severity, pain interference, or quality of life
Study design Randomized clinical trials, observational studies with a nonexposed cohort, observational studies with baseline evaluation, with at least 10 patients in the intervention arm